Key result
High perivascular fat attenuation index on coronary CTA predicts ~462% greater cardiac mortality.
Why the study?
Does perivascular fat attenuation index (FAI) predict all-cause and cardiac mortality in patients undergoing coronary CTA?
Population
3,912 consecutive patients undergoing clinically indicated coronary CTA in Germany and USA.
Design
Cohort, Images were anonymised locally and transferred to a core laboratory…
Follow-up
Median 72 months in derivation cohort and 54 months in…
Authors
Loading...
High FAI on coronary CTA may refine mortality risk stratification; leaves open incremental value and clinical adoption pending prospective trials.
Does perivascular fat attenuation index (FAI) predict all-cause and cardiac mortality in patients undergoing coronary CTA?
Perivascular FAI measured on routine coronary CTA provides a quantitative measure of coronary inflammation that significantly improves cardiac risk prediction and restratification beyond current state-of-the-art assessment.
Oikonomou et al. (2018) studied this question. High perivascular fat attenuation index (≥−70.1 HU) on coronary CTA significantly predicted increased cardiac mortality in derivation (HR 9.04) and validation (HR 5.62) cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: